ALZHEIMER’S TREATMENT CENTERS OF AMERICA – INVESTOR PRESENTATION LIVE FROM NOBLECON [Video]

https://AlzheimersTreatmentCentersOfAmerica.com
#alzheimers #dementia #endalz #investor #investing #investment #angelinvestors #ai

What We Do:
Artificial Intelligence (AI) + Personalized Precision Medicine is the Future of Medicine.

ALZHEIMER’S TREATMENT CENTERS OF AMERICA (ATCA) only treats Alzheimer’s, Dementia, & Cognitive Impairment and uses Artificial Intelligence (AI) (down to your DNA) to do that. In the study on our AI protocol, 75% of the patients had NO FURTHER DECLINE in their Mild Cognitive Impairment. These are amazing results. Our AI System utilizes the immense analytical power of supercomputers to identify patterns, gives automated insights to physicians to improve decision making, streamlines diagnoses, and improves clinical outcomes. ATCA controls the power of these high-tech AI tools through an AI/Human partnership which requires the practitioner to make the final decision.

Who We Are.
– 9 successful MBAs from Harvard (6) + Duke (1) MBA, Michigan (1), and Copenhagen (1)
– 6 renowned Doctors from Harvard (2), Oxford, Columbia, Ohio State, Meharry + a Neurologist
– 3 world class influencers for marketing purposes with huge social media reach
– Our seasoned management team is led by Greg Buckley (HBS) who has run billion-dollar companies including Medical Businesses, Progressive Insurance, PepsiCo and Gibson Guitars.

https://calendly.com/dougco/doug-investor-meeting

ACCREDITED INVESTORS ONLY
Alzheimer’s Treatment Centers of America is currently raising $10 MM in a Convertible Note with a 12% PIK converting into stock in 3 years. There are specific trigger events, so please contact DOUGLAS COLLINS, DIRECTOR OF BUSINESS DEVELOPMENT AND INVESTOR RELATIONS at 775-742-8403 for more information or at [email protected].

This communication does not constitute an offer nor a solicitation of an offer to buy or sell any securities. An offer can only be made through a prospectus or subscription documents.